Kenneth Rivers
Directeur/Membre du Conseil chez COLISEUM ACQUISITION CORP.
Profil
Kenneth Rivers is an Independent Director at Coliseum Acquisition Corp.
He previously worked as the Chief Administration Officer at CHA Health Systems, Inc. Mr. Rivers completed his undergraduate degree at Brown University and holds a graduate degree, including an MBA, from the University of La Verne.
Postes actifs de Kenneth Rivers
| Sociétés | Poste | Début |
|---|---|---|
| COLISEUM ACQUISITION CORP. | Directeur/Membre du Conseil | 25/07/2023 |
Anciens postes connus de Kenneth Rivers
| Sociétés | Poste | Fin |
|---|---|---|
CHA Health Systems, Inc.
 CHA Health Systems, Inc. Medical/Nursing ServicesHealth Services Part of Cha Biotech Co., Ltd., CHA Health Systems, Inc. is a leader in the biotechnology industry. The company is based in Los Angeles, CA. CHA Health Systems delivers world-class care in all facets of medicine, with a focus on fertility and cutting-edge therapies using cord blood stem cells and immune cells. The company is known for their research and clinical work in these fields. CHA Health Systems consists of 81 hospitals and clinics, 30 research and 14 education institutions, and 31 bio/pharmaceutical/healthcare companies in seven countries. The CEO of the company is Yong-Seok Kim. | Directeur Général | 01/01/2014 |
Formation de Kenneth Rivers
| Brown University | Undergraduate Degree |
| University of La Verne | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| COLISEUM ACQUISITION CORP. | Finance |
| Entreprise privées | 1 |
|---|---|
CHA Health Systems, Inc.
CHA Health Systems, Inc. Medical/Nursing ServicesHealth Services Part of Cha Biotech Co., Ltd., CHA Health Systems, Inc. is a leader in the biotechnology industry. The company is based in Los Angeles, CA. CHA Health Systems delivers world-class care in all facets of medicine, with a focus on fertility and cutting-edge therapies using cord blood stem cells and immune cells. The company is known for their research and clinical work in these fields. CHA Health Systems consists of 81 hospitals and clinics, 30 research and 14 education institutions, and 31 bio/pharmaceutical/healthcare companies in seven countries. The CEO of the company is Yong-Seok Kim. | Health Services |
